HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG
PURDUE PHARMA
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG in Canada?
Not currently. The most recent shortage report for HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG is marked resolved (last updated July 23, 2026).
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02125323
Strength
3MG
Dosage Form
CAPSULE (SUSTAINED-RELEASE)
Route
ORAL
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Tier
Unrated
Last Updated
2026-07-23
Reason for Shortage
Demand increase for the drug.
Other Products from PURDUE PHARMA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
75MCG · DIN 02465221
150MCG · DIN 02465248
300MCG · DIN 02465256
450MCG · DIN 02465264
10MCG · DIN 02341212
15MCG · DIN 02450771
20MCG · DIN 02341220
5MCG · DIN 02341174
100MG · DIN 02163748
150MG · DIN 02163780
200MG · DIN 02163799
50MG · DIN 02230302